Requiring the Maryland Medical Assistance Program, subject to the limitations of the State budget, to provide coverage for any medically appropriate drugs that are approved by the United States Food and Drug Administration for the treatment of hepatitis C, regardless of the fibrosis score, and that are determined to be medically necessary.